The number of deals announced in the global healthcare sector, including pharmaceuticals and medical equipment, grew by 13.7% during the week ended June 7, 2020 compared to the previous week, according to GlobalData’s deals database.

Aurojyoti Bose, Lead Analyst at GlobalData, comments: “although the healthcare sector has been relatively resilient compared to other sectors, uncertainty and volatile market conditions due to the COVID-19 outbreak caused deal activity in the sector to be inconsistent over the last few weeks. Growth in deal activity during the week ended June 7 followed a decline the previous week.”

Deal activity has also remained inconsistent across geographies since the COVID-19 outbreak. While activity increased in key markets such as the US, the UK, Japan and China during the week ended June 7, 2020, Canada, France and Australia witnessed decline.

Mergers and acquisitions (M&A), partnerships, equity offerings and venture financing deals volume increased by 78.6%, 24.2%, 14.6% and 19.4%, respectively, during the week ended June 7, 2020 compared to the previous week, while the number of licensing agreement deals declined by 36.4%.